XML 19 R4.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Operating expenses:    
Research and development $ 36,571 $ 32,130
General and administrative 5,862 5,942
Total operating expenses 42,433 38,072
Total operating loss (42,433) (38,072)
Other income (expense):    
Interest income 338 230
Interest expense (5,540) (2,792)
Change in fair value of derivatives 588 (432)
Total other expense (4,614) (2,994)
Net loss (47,047) (41,066)
Preferred stock dividends (153) (120)
Warrant modification 0 (3,619)
Net loss applicable to common stockholders $ (47,200) $ (44,805)
Net loss per common share - basic (in dollars per share) $ (0.76) $ (0.74)
Net loss per common share - diluted (in dollars per share) $ (0.76) $ (0.74)
Weighted average common and potential common shares outstanding - basic (in shares) 62,309 60,159
Weighted average common and potential common shares outstanding - diluted (in shares) 62,309 60,159